This article is a retraction of:
RETRACTED: Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM
A Retraction of the Original Research Article
Establishment of criteria for molecular differential diagnosis of MPLC and IPM
By Wang X, Gong Y, Yao J, Chen Y, Li Y, Zeng Z, Lu Y and Song L (2021). Front. Oncol. 10:614430. doi: 10.3389/fonc.2020.614430
Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that they discovered a fault in their experimental design that rendered the conclusion unreliable. An investigation was conducted in accordance with Frontiers’ policies that confirmed this; therefore, the article has been retracted.
This retraction was approved by the Chief Editors of Oncology and the Chief Executive Editor of Frontiers. The authors agree to proceed with the retraction and sincerely regret any inconvenience this may have caused to the reviewers, editors and readers of Frontiers in Oncology.
Citation: Frontiers Editorial Office (2024) Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM. Front. Oncol. 14:1399853. doi: 10.3389/fonc.2024.1399853
Received: 12 March 2024; Accepted: 12 March 2024;
Published: 20 March 2024.
Approved by:
Giuseppe Giaccone, Vice President Global Development, United StatesCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org